A multicenter, 12-month, open-label, single-arm, safety study of oxycodone hydrochloride and naltrexone hydrochloride extended-release capsules (ALO-02) in patients with moderate to severe chronic non-cancer pain

✍ Scribed by Setnik, B.; Arora, S.; Drass, M.; Hudson, J.; Clemmer, R.; Meisner, P.; Pixton, G.; Sommerville, K.

• Book ID: 123061147
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 93 KB
• Volume: 14
• Category: Article
• ISSN: 1528-8447
• DOI: 10.1016/j.jpain.2013.01.654